Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage. View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-02-21

AUTHORS

Anna Buigues, Maria Marchante, Sonia Herraiz, Antonio Pellicer

ABSTRACT

Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we aimed to evaluate whether chemotherapy treatment in mice could reproduce features similar of that observed in women with DOR. Twenty-one Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were allocated to 3 groups (n = 7/group): control, single dose of vehicle (Dimethyl Sulfoxide [DMSO]); DOR, single reduced chemotherapy dose; and POI, single standard chemotherapy dose. After 21 days, mice underwent ovarian hyperstimulation and mating. Part of the animals were harvested to analyze ovarian reserve, ovulation and fertilization rates, and morphology, apoptosis, and vascularization of the ovarian stroma. The remaining mice underwent multiple matings to assess pregnancy rates and litter sizes. The DOR and POI mice showed an impaired estrous cyclicity and a decrease in ovarian mass, number of follicles, Metaphase II (MII) oocytes, and embryos as well as in ovarian stroma vascularization. Mice in both models showed also an increase in the percentage of morphologically abnormal follicles, stromal degeneration, and apoptosis. Similar to that observed in DOR and POI patients, these impairments were less severe in DOR than in POI mice. None of the POI females were able to achieve a pregnancy. Meanwhile, DOR females achieved several consecutive pregnancies, although litter size was decreased when compared to controls. In conclusion, a mouse model which displayed most of the ovarian characteristics and fertility outcomes of women with DOR has been established using a single dose of chemotherapy. More... »

PAGES

1933719119831784

Identifiers

URI

http://scigraph.springernature.com/pub.10.1177/1933719119831784

DOI

http://dx.doi.org/10.1177/1933719119831784

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112291919

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30791852


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Paediatrics and Reproductive Medicine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain.", 
          "id": "http://www.grid.ac/institutes/grid.5338.d", 
          "name": [
            "1 IVI Foundation, Valencia Spain.", 
            "2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buigues", 
        "givenName": "Anna", 
        "id": "sg:person.011724070757.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011724070757.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain.", 
          "id": "http://www.grid.ac/institutes/grid.5338.d", 
          "name": [
            "1 IVI Foundation, Valencia Spain.", 
            "2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marchante", 
        "givenName": "Maria", 
        "id": "sg:person.010363147373.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010363147373.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "4 IVI-RMA Valencia, Valencia, Spain.", 
          "id": "http://www.grid.ac/institutes/grid.419275.c", 
          "name": [
            "1 IVI Foundation, Valencia Spain.", 
            "3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain.", 
            "4 IVI-RMA Valencia, Valencia, Spain."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herraiz", 
        "givenName": "Sonia", 
        "id": "sg:person.0725244145.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725244145.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "5 IVI-RMA Rome, Rome, Italy.", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "1 IVI Foundation, Valencia Spain.", 
            "3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain.", 
            "5 IVI-RMA Rome, Rome, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pellicer", 
        "givenName": "Antonio", 
        "id": "sg:person.01125174440.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125174440.05"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature02316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031245923", 
          "https://doi.org/10.1038/nature02316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10815-015-0595-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036792268", 
          "https://doi.org/10.1007/s10815-015-0595-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009505802", 
          "https://doi.org/10.1038/nature04929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1702695", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048075300", 
          "https://doi.org/10.1038/sj.bmt.1702695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1631/jzus.b1200181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050882124", 
          "https://doi.org/10.1631/jzus.b1200181"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-21", 
    "datePublishedReg": "2019-02-21", 
    "description": "Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we aimed to evaluate whether chemotherapy treatment in mice could reproduce features similar of that observed in women with DOR. Twenty-one Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were allocated to 3 groups (n = 7/group): control, single dose of vehicle (Dimethyl Sulfoxide [DMSO]); DOR, single reduced chemotherapy dose; and POI, single standard chemotherapy dose. After 21 days, mice underwent ovarian hyperstimulation and mating. Part of the animals were harvested to analyze ovarian reserve, ovulation and fertilization rates, and morphology, apoptosis, and vascularization of the ovarian stroma. The remaining mice underwent multiple matings to assess pregnancy rates and litter sizes. The DOR and POI mice showed an impaired estrous cyclicity and a decrease in ovarian mass, number of follicles, Metaphase II (MII) oocytes, and embryos as well as in ovarian stroma vascularization. Mice in both models showed also an increase in the percentage of morphologically abnormal follicles, stromal degeneration, and apoptosis. Similar to that observed in DOR and POI patients, these impairments were less severe in DOR than in POI mice. None of the POI females were able to achieve a pregnancy. Meanwhile, DOR females achieved several consecutive pregnancies, although litter size was decreased when compared to controls. In conclusion, a mouse model which displayed most of the ovarian characteristics and fertility outcomes of women with DOR has been established using a single dose of chemotherapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1177/1933719119831784", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1112196", 
        "issn": [
          "1933-7191", 
          "1933-7205"
        ], 
        "name": "Reproductive Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "primary ovarian insufficiency", 
      "POI mice", 
      "ovarian reserve", 
      "chemotherapy dose", 
      "single dose", 
      "mouse model", 
      "number of follicles", 
      "appropriate animal models", 
      "nonobese diabetic/", 
      "new therapeutic strategies", 
      "metaphase II oocytes", 
      "stromal degeneration", 
      "ovarian hyperstimulation", 
      "ovarian damage", 
      "ovarian masses", 
      "POI patients", 
      "ovarian stroma", 
      "consecutive pregnancies", 
      "chemotherapy treatment", 
      "abnormal follicles", 
      "female mice", 
      "pregnancy rate", 
      "estrous cyclicity", 
      "ovarian insufficiency", 
      "diabetic/", 
      "therapeutic strategies", 
      "preclinical assessment", 
      "new therapies", 
      "ovarian characteristics", 
      "animal models", 
      "fertility outcomes", 
      "litter size", 
      "mice", 
      "dose", 
      "pregnancy", 
      "fertilization rate", 
      "follicles", 
      "women", 
      "vascularization", 
      "DOR", 
      "apoptosis", 
      "females", 
      "hyperstimulation", 
      "chemotherapy", 
      "patients", 
      "infertility", 
      "therapy", 
      "insufficiency", 
      "ovulation", 
      "degeneration", 
      "stroma", 
      "impairment", 
      "outcomes", 
      "treatment", 
      "control", 
      "days", 
      "animals", 
      "oocytes", 
      "rate", 
      "conclusion", 
      "group", 
      "percentage", 
      "damage", 
      "assessment", 
      "factors", 
      "decrease", 
      "study", 
      "primary factor", 
      "increase", 
      "lack", 
      "embryos", 
      "reserves", 
      "cyclicity", 
      "mating", 
      "mass", 
      "strategies", 
      "model", 
      "number", 
      "size", 
      "features", 
      "characteristics", 
      "part", 
      "tool", 
      "morphology", 
      "vehicles", 
      "multiple mating", 
      "immunodeficiency (NOD/SCID) female mice", 
      "single reduced chemotherapy dose", 
      "reduced chemotherapy dose", 
      "single standard chemotherapy dose", 
      "standard chemotherapy dose", 
      "impaired estrous cyclicity", 
      "II (MII) oocytes", 
      "ovarian stroma vascularization", 
      "stroma vascularization", 
      "POI females", 
      "DOR females", 
      "Ovarian Reserve Chemotherapy-Induced Mouse Model", 
      "Reserve Chemotherapy-Induced Mouse Model", 
      "Chemotherapy-Induced Mouse Model"
    ], 
    "name": "Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage.", 
    "pagination": "1933719119831784", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112291919"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1177/1933719119831784"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30791852"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1177/1933719119831784", 
      "https://app.dimensions.ai/details/publication/pub.1112291919"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_793.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1177/1933719119831784"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'


 

This table displays all metadata directly associated to this object as RDF triples.

212 TRIPLES      22 PREDICATES      130 URIs      116 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1177/1933719119831784 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 anzsrc-for:1114
4 schema:author Nb2c19003945b43939bde2b7bc664251c
5 schema:citation sg:pub.10.1007/s10815-015-0595-y
6 sg:pub.10.1038/nature02316
7 sg:pub.10.1038/nature04929
8 sg:pub.10.1038/sj.bmt.1702695
9 sg:pub.10.1631/jzus.b1200181
10 schema:datePublished 2019-02-21
11 schema:datePublishedReg 2019-02-21
12 schema:description Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we aimed to evaluate whether chemotherapy treatment in mice could reproduce features similar of that observed in women with DOR. Twenty-one Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were allocated to 3 groups (n = 7/group): control, single dose of vehicle (Dimethyl Sulfoxide [DMSO]); DOR, single reduced chemotherapy dose; and POI, single standard chemotherapy dose. After 21 days, mice underwent ovarian hyperstimulation and mating. Part of the animals were harvested to analyze ovarian reserve, ovulation and fertilization rates, and morphology, apoptosis, and vascularization of the ovarian stroma. The remaining mice underwent multiple matings to assess pregnancy rates and litter sizes. The DOR and POI mice showed an impaired estrous cyclicity and a decrease in ovarian mass, number of follicles, Metaphase II (MII) oocytes, and embryos as well as in ovarian stroma vascularization. Mice in both models showed also an increase in the percentage of morphologically abnormal follicles, stromal degeneration, and apoptosis. Similar to that observed in DOR and POI patients, these impairments were less severe in DOR than in POI mice. None of the POI females were able to achieve a pregnancy. Meanwhile, DOR females achieved several consecutive pregnancies, although litter size was decreased when compared to controls. In conclusion, a mouse model which displayed most of the ovarian characteristics and fertility outcomes of women with DOR has been established using a single dose of chemotherapy.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree false
16 schema:isPartOf sg:journal.1112196
17 schema:keywords Chemotherapy-Induced Mouse Model
18 DOR
19 DOR females
20 II (MII) oocytes
21 Ovarian Reserve Chemotherapy-Induced Mouse Model
22 POI females
23 POI mice
24 POI patients
25 Reserve Chemotherapy-Induced Mouse Model
26 abnormal follicles
27 animal models
28 animals
29 apoptosis
30 appropriate animal models
31 assessment
32 characteristics
33 chemotherapy
34 chemotherapy dose
35 chemotherapy treatment
36 conclusion
37 consecutive pregnancies
38 control
39 cyclicity
40 damage
41 days
42 decrease
43 degeneration
44 diabetic/
45 dose
46 embryos
47 estrous cyclicity
48 factors
49 features
50 female mice
51 females
52 fertility outcomes
53 fertilization rate
54 follicles
55 group
56 hyperstimulation
57 immunodeficiency (NOD/SCID) female mice
58 impaired estrous cyclicity
59 impairment
60 increase
61 infertility
62 insufficiency
63 lack
64 litter size
65 mass
66 mating
67 metaphase II oocytes
68 mice
69 model
70 morphology
71 mouse model
72 multiple mating
73 new therapeutic strategies
74 new therapies
75 nonobese diabetic/
76 number
77 number of follicles
78 oocytes
79 outcomes
80 ovarian characteristics
81 ovarian damage
82 ovarian hyperstimulation
83 ovarian insufficiency
84 ovarian masses
85 ovarian reserve
86 ovarian stroma
87 ovarian stroma vascularization
88 ovulation
89 part
90 patients
91 percentage
92 preclinical assessment
93 pregnancy
94 pregnancy rate
95 primary factor
96 primary ovarian insufficiency
97 rate
98 reduced chemotherapy dose
99 reserves
100 single dose
101 single reduced chemotherapy dose
102 single standard chemotherapy dose
103 size
104 standard chemotherapy dose
105 strategies
106 stroma
107 stroma vascularization
108 stromal degeneration
109 study
110 therapeutic strategies
111 therapy
112 tool
113 treatment
114 vascularization
115 vehicles
116 women
117 schema:name Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage.
118 schema:pagination 1933719119831784
119 schema:productId N7fe9b97a699f424f9c662b6c7c96661b
120 Nc2ba617f573f45e489fc6d957be4a7d6
121 Nd334104d365643cc83c86e536e7a873e
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112291919
123 https://doi.org/10.1177/1933719119831784
124 schema:sdDatePublished 2022-01-01T18:47
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher Nd0ef93970f784c688b3175e23307d9c9
127 schema:url https://doi.org/10.1177/1933719119831784
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N17639fb28f314278a21eee705ec67565 rdf:first sg:person.0725244145.42
132 rdf:rest Neecc461afa6e4d489f07ebd099a02d86
133 N6262f1c2687b4f878e140dd1038e2bda rdf:first sg:person.010363147373.02
134 rdf:rest N17639fb28f314278a21eee705ec67565
135 N7fe9b97a699f424f9c662b6c7c96661b schema:name doi
136 schema:value 10.1177/1933719119831784
137 rdf:type schema:PropertyValue
138 Nb2c19003945b43939bde2b7bc664251c rdf:first sg:person.011724070757.34
139 rdf:rest N6262f1c2687b4f878e140dd1038e2bda
140 Nc2ba617f573f45e489fc6d957be4a7d6 schema:name pubmed_id
141 schema:value 30791852
142 rdf:type schema:PropertyValue
143 Nd0ef93970f784c688b3175e23307d9c9 schema:name Springer Nature - SN SciGraph project
144 rdf:type schema:Organization
145 Nd334104d365643cc83c86e536e7a873e schema:name dimensions_id
146 schema:value pub.1112291919
147 rdf:type schema:PropertyValue
148 Neecc461afa6e4d489f07ebd099a02d86 rdf:first sg:person.01125174440.05
149 rdf:rest rdf:nil
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
154 schema:name Oncology and Carcinogenesis
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1114 schema:inDefinedTermSet anzsrc-for:
157 schema:name Paediatrics and Reproductive Medicine
158 rdf:type schema:DefinedTerm
159 sg:journal.1112196 schema:issn 1933-7191
160 1933-7205
161 schema:name Reproductive Sciences
162 schema:publisher Springer Nature
163 rdf:type schema:Periodical
164 sg:person.010363147373.02 schema:affiliation grid-institutes:grid.5338.d
165 schema:familyName Marchante
166 schema:givenName Maria
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010363147373.02
168 rdf:type schema:Person
169 sg:person.01125174440.05 schema:affiliation grid-institutes:None
170 schema:familyName Pellicer
171 schema:givenName Antonio
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125174440.05
173 rdf:type schema:Person
174 sg:person.011724070757.34 schema:affiliation grid-institutes:grid.5338.d
175 schema:familyName Buigues
176 schema:givenName Anna
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011724070757.34
178 rdf:type schema:Person
179 sg:person.0725244145.42 schema:affiliation grid-institutes:grid.419275.c
180 schema:familyName Herraiz
181 schema:givenName Sonia
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725244145.42
183 rdf:type schema:Person
184 sg:pub.10.1007/s10815-015-0595-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1036792268
185 https://doi.org/10.1007/s10815-015-0595-y
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/nature02316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031245923
188 https://doi.org/10.1038/nature02316
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/nature04929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009505802
191 https://doi.org/10.1038/nature04929
192 rdf:type schema:CreativeWork
193 sg:pub.10.1038/sj.bmt.1702695 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048075300
194 https://doi.org/10.1038/sj.bmt.1702695
195 rdf:type schema:CreativeWork
196 sg:pub.10.1631/jzus.b1200181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050882124
197 https://doi.org/10.1631/jzus.b1200181
198 rdf:type schema:CreativeWork
199 grid-institutes:None schema:alternateName 5 IVI-RMA Rome, Rome, Italy.
200 schema:name 1 IVI Foundation, Valencia Spain.
201 3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain.
202 5 IVI-RMA Rome, Rome, Italy.
203 rdf:type schema:Organization
204 grid-institutes:grid.419275.c schema:alternateName 4 IVI-RMA Valencia, Valencia, Spain.
205 schema:name 1 IVI Foundation, Valencia Spain.
206 3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain.
207 4 IVI-RMA Valencia, Valencia, Spain.
208 rdf:type schema:Organization
209 grid-institutes:grid.5338.d schema:alternateName 2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain.
210 schema:name 1 IVI Foundation, Valencia Spain.
211 2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain.
212 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...